Biotechnology
Regeneron Stock Is Attempting an Upside Breakout
Let's check to see if these gains by the biotech can be sustained.
Biogen and Lilly: How I'm Playing the Alzheimer's Drug Stocks Game
Let's size up the prospects for treatments and the shares.
As Biogen Surges on Alzheimer Trial Results, Here's How to Play It
BIIB shares have jumped around 50% in early trading activity Wednesday.
This Infection-Fighting Biotech Is Recovering Nicely
After a deal with GlaxoSmithKline, the small-cap antibiotic developer Spero Therapeutics should get a shot as an options play.
Novavax's Covid Vaccine May Pinch, But the Charts Really Hurt
Shares of Novavax are looking weak and in need of a booster, according to the technicals.
My Strategy to Buy Beam Therapeutics
Let's look at the charts and indicators.
Nuvalent Has Made a Base Pattern on the Charts
This biopharmaceutical firm shows promise.
Here Are a Few Trading Dice to Consider Rolling Ahead of the Fed's Rate News
There are still pockets of strength if you're willing to dig deep, though it's crucial to have crystal-clear stop levels to avert serious losses.
Bearish Bets: 3 Stocks You Should Think About Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
Should Investors Buy a Pullback in Gilead Sciences?
The charts give us an answer.